ImmunoCAP Specific IgE measures the concentration of circulating allergen-specific IgE antibodies in human serum or plasma.
This helps to identify specific allergens (and allergen components) and predict the development of allergic disease to aid in the reliable diagnosis of patients with suspected allergy. With over 650 allergens and 90 components available, ImmunoCAP Specific IgE offers precise and comprehensive antibody testing.
Test results that translate into improved patient care
With ImmunoCAP Specific IgE, the relationship between antibody levels, sensitisation, and the presence of clinical allergy can be demonstrated. With this precise, truly quantitative test, IgE antibody formation can be detected
at an early stage, even before clinical symptoms have evolved. This enables physicians to select the best strategy for managing the disease and to avoid
the development of a severe, chronic condition.
Download Quality Club Specific IgE Directions for Use